Functional relationship between subfornical organ cholinergic stimulation and cellular activation in the hypothalamus and AV3V region

Brain Res. 2001 Dec 20;922(2):191-200. doi: 10.1016/s0006-8993(01)03166-3.

Abstract

The subfornical organ (SFO) has been suggested to be important for water intake and secretion of vasopressin (AVP). However, the role of the SFO cholinergic mechanism in the control of body fluid regulation is not clear. This study determined the effects of local cholinergic stimulation in the SFO produced by administration of physostigmine on drinking and cellular excitation in the anterior third ventricle (AV3V) region and in the supraoptic and paraventricular nuclei (SON and PVN). The results showed that injection of physostigmine into the SFO induced water intake and c-fos expression in the AV3V area as well as in the AVP containing neurons in the hypothalamus. Pretreatment of the SFO with mecamylamine, a nicotinic receptor antagonist, had no effect on physostigmine induced behavioral and c-fos responses. The muscarinic receptor blocker atropine, however, abolished both drinking and cellular activation after injection of physostigmine into the SFO. Immunostaining experiments demonstrated positive acetyltransferase (ChAT) in the SFO. Intensive ChAT immunoreactivity was located in the cholinergic fibers in the SFO. Together, the results indicate that SFO cholinergic mechanisms are important in co-operation with the AV3V and hypothalamic neurons in the control of thirst and AVP-mediated body fluid homeostasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / metabolism*
  • Animals
  • Atropine / pharmacology
  • Cholinergic Fibers / drug effects
  • Cholinergic Fibers / metabolism*
  • Cholinergic Fibers / ultrastructure
  • Cholinesterase Inhibitors / pharmacology
  • Drinking / drug effects
  • Drinking / physiology
  • Hypothalamus / cytology
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism*
  • Immunohistochemistry
  • Male
  • Mecamylamine / pharmacology
  • Muscarinic Antagonists / pharmacology
  • Neural Pathways / cytology
  • Neural Pathways / drug effects
  • Neural Pathways / metabolism*
  • Neurons / cytology
  • Neurons / drug effects
  • Neurons / metabolism*
  • Nicotinic Antagonists / pharmacology
  • Paraventricular Hypothalamic Nucleus / cytology
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / metabolism
  • Physostigmine / pharmacology
  • Preoptic Area / cytology
  • Preoptic Area / drug effects
  • Preoptic Area / metabolism
  • Proto-Oncogene Proteins c-fos / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Solitary Nucleus / cytology
  • Solitary Nucleus / drug effects
  • Solitary Nucleus / metabolism
  • Subfornical Organ / cytology
  • Subfornical Organ / drug effects
  • Subfornical Organ / metabolism*
  • Third Ventricle / cytology
  • Third Ventricle / drug effects
  • Third Ventricle / metabolism*
  • Vasopressins / drug effects
  • Vasopressins / metabolism
  • Water-Electrolyte Balance / drug effects
  • Water-Electrolyte Balance / physiology

Substances

  • Cholinesterase Inhibitors
  • Muscarinic Antagonists
  • Nicotinic Antagonists
  • Proto-Oncogene Proteins c-fos
  • Vasopressins
  • Mecamylamine
  • Atropine
  • Physostigmine
  • Acetylcholine